Get the latest tech news
Novartis to buy RNA-focused Avidity in $12 billion deal
Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks to grow its pipeline.
None
Or read this on r/technology